234 A phase 1, open-label, dose-finding study to assess the safety and tolerability of U3 1287 (AMG 888), a human monoclonal antibody targeting HER3 in patients with advanced solid tumors

Autor: LoRusso, P., Keedy, V., Yee, L., Oliveira, M., Rizvi, N., Berlin, J., Jin, X., Hettmann, T., Copigneaux, C., Beaupre, D.
Zdroj: In EJC Supplements 2010 8(7):76-76
Databáze: ScienceDirect
Externí odkaz: